RxDoctor Payments Data

Bhavik Patel, MD

Hospitalist · Tulsa, OKNPI 1013234996

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,144 of the $1,629 with a category attached, or 70.2%. 12 manufacturers reported payments, led by Medtronic at 29.8% of the total. Reporting peaked in 2019 at $772 and has fallen 69.4% since, to $236 in 2025. Among hospitalist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,629in general payments, 2019–2025

Across 16 payments — averaging $101.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$485
  • Novartis$249
  • AbbVie$227
  • Johnson & Johnson$148
  • Penumbra, Inc.$144
  • Sanofi-aventis U.S. LLC$116
  • plus $261 from 6 others

What the payments were for

  • Travel & lodging$48530%
  • Food & beverage$1,14470%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,629 in reported general payments places this provider in the 95th percentile of 234 hospitalist providers in Oklahoma.

See all hospitalist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$111,546
Medicare patients
326
Services billed
1,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$29,701
EliquisApixaban31$17,895
BrilintaTicagrelor13$7,968
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav33$350
Albuterol Sulfate HfaAlbuterol Sulfate12$286
Metoprolol Succinate15$261
Celecoxib21$209
Torsemide14$165
Atorvastatin Calcium17$153
ClopidogrelClopidogrel Bisulfate15$147
Pantoprazole Sodium11$128
Spironolactone18$127
Levofloxacin17$125
Carvedilol22$111
Metoprolol Tartrate13$90

Paid to pharmacies, not to this prescriber.

Other hospitalist in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →